116 related articles for article (PubMed ID: 11364952)
1. Efavirenz (Sustiva) expanded access now to 400 CD4.
AIDS Treat News; 1998 Jan; (No 286):5. PubMed ID: 11364952
[TBL] [Abstract][Full Text] [Related]
2. DMP 266 (Sustiva) expanded access.
Vazquez E; Whitfield L
Posit Aware; 1997; 8(6):12. PubMed ID: 11364850
[TBL] [Abstract][Full Text] [Related]
3. Efavirenz expanded access broadened.
Highleyman L
BETA; 1998 Apr; ():3. PubMed ID: 11365262
[TBL] [Abstract][Full Text] [Related]
4. Broadened access to Sustiva.
Bornhoeft MA
Body Posit; 1998 Jan; 11(1):13. PubMed ID: 11365007
[TBL] [Abstract][Full Text] [Related]
5. DMP 266 now available.
Gilden D
GMHC Treat Issues; 1997 Sep; 11(9):5-6. PubMed ID: 11364751
[TBL] [Abstract][Full Text] [Related]
6. Efavirenz expanded access.
Highleyman L
BETA; 1998 Jan; ():4. PubMed ID: 11364975
[TBL] [Abstract][Full Text] [Related]
7. Expanded access programs.
Treat Rev; 1997 Nov; (No 26-27):12. PubMed ID: 11364931
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz (SUSTIVA) expanded access begins October 1.
James JS
AIDS Treat News; 1997 Sep; (No 279):1-2. PubMed ID: 11364689
[TBL] [Abstract][Full Text] [Related]
9. Expanded access.
Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365207
[TBL] [Abstract][Full Text] [Related]
10. Efavirenz (Sustiva) available through patient assistance program.
AIDS Treat News; 1998 Nov; (No 306):4. PubMed ID: 11365962
[TBL] [Abstract][Full Text] [Related]
11. More expanded access for DMP 266.
Vazquez E
Posit Aware; 1998; 9(2):15. PubMed ID: 11365220
[TBL] [Abstract][Full Text] [Related]
12. DMP 266 on the horizon.
Vazquez E
Posit Aware; 1997; 8(5):25. PubMed ID: 11364636
[TBL] [Abstract][Full Text] [Related]
13. Efavirenz (SUSTIVA) approved.
James JS
AIDS Treat News; 1998 Oct; (No 304):1-4. PubMed ID: 11365862
[TBL] [Abstract][Full Text] [Related]
14. Efavirenz (Sustiva) receives FDA approval. Food and Drug Administration.
Proj Inf Perspect; 1998 Dec; (26):11. PubMed ID: 11366487
[TBL] [Abstract][Full Text] [Related]
15. Options when HIV treatments fail.
Treat Rev; 1998; (No 28):7-9. PubMed ID: 11365426
[TBL] [Abstract][Full Text] [Related]
16. Efavirenz (Sustiva): oral liquid expanded access program for children and adolescents ages 3-16.
AIDS Treat News; 2000 May; (342):4. PubMed ID: 12870459
[TBL] [Abstract][Full Text] [Related]
17. Sustiva (efavirenz) is approved.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366471
[TBL] [Abstract][Full Text] [Related]
18. New drug approved.
AIDS Policy Law; 1998 Oct; 13(18):12. PubMed ID: 11365934
[TBL] [Abstract][Full Text] [Related]
19. FDA approves efavirenz. Food and Drug Administration.
Highleyman L
BETA; 1998 Oct; ():3. PubMed ID: 11365987
[TBL] [Abstract][Full Text] [Related]
20. FDA approves Sustiva (efavirenz) capsules, first once-daily anti-HIV drug. Food and Drug Administration.
Res Initiat Treat Action; 1998 Oct; 4(6):13-4. PubMed ID: 11365915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
